Elevance Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Elevance Health, Inc. on May 14, 2025. The filing details the voting outcomes for director elections, executive compensation, auditor ratification, and a shareholder proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: All three nominees (Susan D. DeVore, Bahija Jallal, and Ryan M. Schneider) were elected to three-year terms expiring in 2028.
- Susan D. DeVore: 185,839,586 For; 3,726,860 Against.
- Bahija Jallal: 180,810,837 For; 8,752,093 Against.
- Ryan M. Schneider: 184,627,201 For; 4,951,857 Against.
- Executive Compensation (Say-on-Pay): The advisory vote was approved with 173,964,580 votes For and 15,522,459 votes Against.
- Auditor Ratification: The appointment of Ernst & Young LLP for 2025 was ratified with 178,086,607 votes For and 23,455,317 votes Against.
- Shareholder Proposal (DEI Report): A proposal requesting a report on Diversity, Equity, and Inclusion efforts was not approved. It received 26,240,205 votes For and 160,685,853 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of shareholder voting results.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the full proxy statement for details on the specific Diversity, Equity, and Inclusion proposal that was rejected.
- Confirm the tenure and background of the newly elected directors for the 2025-2028 term.
- Check subsequent filings for the company's Q2 2025 financial results, as this 8-K contains no financial data.